Press release
Parp Inhibitor Market Growth and Future Outlook Industry Insights: Market Size, Share, and Growth Forecast 2024 - 2031 | Sierra Oncology, Inc., KaryopharmTherapeutics Inc., Ono Pharmaceutical Co., Ltd
Global Parp Inhibitor Market is estimated to be valued at USD 7.20 Bn in 2024 and is expected to reach USD 13.02 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.A new study titled Parp Inhibitor Market 2024, published by the Coherent Market Insights, offers information on regional and global markets that is expected to increase in value between 2024 and 2031. The extensive research offers important visions into the market's shifting dynamics, value chain analysis, well-known investment hotspots, competitive scenarios, regional landscape, and major segments. It also offers a whole analysis of the controls and restraints for the worldwide market. Also provides outstanding information on the strategies and opportunities used in the market. This will help those working in the business, policymakers, stakeholders, investors and newcomers to the Market size opportunities, pinpoint crucial tactics, and gain an edge over rivals.
Parp Inhibitor Market Research makes a specialty of the important thing traits winning with inside the Global Parp Inhibitor Market sector. The present Market situation has been studied and destiny projections with appreciation to the arena have additionally been investigated. The market observation file contains an assessment of several influential elements together with an enterprise review in phrases of anciental and gift situation, key manufacturers, software and types, key areas and marketplaces, forecast estimation for international marketplace share, sales, and CAGR.
💡Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/3037
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.
Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Parp Inhibitor companies, key tactics followed by Leading Key Players:
â—˜ AstraZeneca
â—˜ GlaxoSmithKline
â—˜ Merck Co. & Inc
â—˜ GlaxoSmithKline plc
â—˜ AbbVie Inc
â—˜ Clovis Oncology
â—˜ Medivation
â—˜ Johnson & Johnson Services Inc
â—˜ Pfizer Inc.
â—˜ Repare Therapeutics Inc.
â—˜ Genentech Inc.
â—˜ Artios Pharma
â—˜ Repare Therapeutics Inc.
â—˜ Sierra Oncology Inc.
â—˜ KaryopharmTherapeutics Inc.
â—˜ Ono Pharmaceutical Co., Ltd.,
â—˜ Jiangsu Hengrui Medicine Co., Ltd.,
Market Segmentation:
â—˜ By Drug Type: Niraparib, Olaparib, Rucaparib, Talazoparib, Veliparib, Others
â—˜ By Application: Ovarian Cancer, Fallopian Tube Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others
â—˜ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Overview and Scope of the Report:
The Parp Inhibitor Market Analysis Report provides a detailed analysis of the market size of various segments and countries in previous years, as well as forecasts for the coming years. The Market report presents a detailed competitive landscape of the global market. The market dynamics, drivers, and segmentation by application, type, region, and manufacturer are all discussed in this report. With respect to the regions and countries covered in the report, this Market report provides both qualitative and quantitative aspects of the industry.
The Study Objectives are:
✦ A comprehensive insight into key players operating in the Parp Inhibitor Market and their corresponding data.
✦ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✦ Regional analysis, which includes insight into the dominant market and corresponding market share.
✦ It also includes various socio-economic factors affecting the evolution of the market in the region.
✦ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
✅Purchase This Premium Research Report and Get Upto 25% Discount at : https://www.coherentmarketinsights.com/insight/buy-now/3037
Deep-dive Analysis:
The Report provides deep-dive qualitative and quantitative analysis on Parp Inhibitor Market for all the regions and countries covered below:
➢ North America (the United States, Canada, and Mexico)
➢ Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe)
➢ Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
➢ South America (Brazil, Argentina, and Rest of South America)
➢ Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa)
➢ Each Country is covered in detail, and report provides qualitative and quantitative analysis on Parp Inhibitor Market on each country.
Key insights provided by the report that could help you take critical strategic decisions?
• Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.
• Reports provide opportunities and threats faced by suppliers in the Parp Inhibitor and tubes industry around the world.
• The report shows regions and sectors with the fastest growth potential.
• A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.
• The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.
• This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
• This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
Table of Contents:
Market scenario 2024
Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Parp Inhibitor market
Chapter 2: Exclusive Summary - the basic information of the Parp Inhibitor Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Parp Inhibitor
Chapter 4: Presenting the Parp Inhibitor Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2024 - 2031
Chapter 6: Evaluating the leading manufacturers of the Parp Inhibitor market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2024-2031)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source
💡Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/3037
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.
Key Questions Answered:
(1) What is the market size and CAGR of the Parp Inhibitor Market during the forecast period?
(2) How is the growing demand impacting the growth of Parp Inhibitor Market shares?
(3) What is the growing demand of the Market during the forecast period?
(4) Who are the leading vendors in the market and what are their market shares?
(5) What are the major threats and challenges likely to act as a barrier in the growth of the Parp Inhibitor market?
Author of this marketing PR:
Priya Pandey is a dynamic and passionate PR writer with over three years of expertise in content writing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes writing contents and documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
☎ Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parp Inhibitor Market Growth and Future Outlook Industry Insights: Market Size, Share, and Growth Forecast 2024 - 2031 | Sierra Oncology, Inc., KaryopharmTherapeutics Inc., Ono Pharmaceutical Co., Ltd here
News-ID: 3684138 • Views: …
More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb …
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…

Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business…

Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by …
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…

Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni …
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…
More Releases for Parp
PARP Inhibitors Market to Surpass USD 12 Billion by 2034,
Introduction
Cancer continues to be one of the most pressing healthcare challenges worldwide, and the demand for targeted, effective therapies has never been greater. Among the most promising innovations are Poly (ADP-ribose) polymerase (PARP) inhibitors, a class of drugs designed to exploit DNA repair weaknesses in cancer cells, particularly those with BRCA1/2 mutations. By preventing cancer cells from repairing DNA damage, PARP inhibitors lead to cell death, offering a new line…
PARP Inhibitor Biomarkers Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitor Biomarkers Market - (By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global PARP Inhibitor Biomarkers Market is valued at US$ 879.8…
China Market Analysis of PARP Inhibitors: Growth Opportunities
Global PARP Inhibitors Market: Introduction
A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA.
Read Report Overview - https://www.transparencymarketresearch.com/parp-inhibitors-market.html
Global PARP Inhibitors Market: Competition Landscape
Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is…
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
PARP Inhibitors Market Dynamics, Segments, Size and Demand, 2017 - 2027
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
Global PARP Inhibitor Market: Size, Trends And Forecasts (2016-2020)
Scope of the Report
The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib.
The report analyses the global Lynparza market in detail along with the regional analysis as…